The city of San Antonio, Texas, currently has 1 active clinical trials seeking participants for Hepatitis B research studies.
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
Recruiting
The primary purpose of this study is to assess the safety and tolerability of single and multiple intravenous (IV) doses of GIGA-2339 in participants with chronic Hepatitis B Virus (HBV) infection.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/08/2025
Locations: Grifols Investigative site, San Antonio, Texas
Conditions: Hepatitis B Virus Infection